Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): AR098201A1
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 26-10-2016
Patent type: Compositions

Click within the document, or manually enter the page number below

CILFA opposition, risedronate / EDTA, (AR098686A2)

Countries: Argentina Date: 2016
CILFA opposition, bempedoic acid, (AR114396A1)

Countries: Argentina Date: 2020
CILFA opposition, clodronic acid, (AR110319A1)

Countries: Argentina Date: 2019
CILFA opposition, Gamma-aminobutiric acid derivatives including gabapentin , pregabalin, baclofen, (P990102313)

Countries: Argentina Date: 2002
CILFA opposition, amino acids, (AR110548A1)

Countries: Argentina Date: 2019
CILFA opposition, omega-3 polyunsaturated acids, (AR110450A1)

Countries: Argentina Date: 2019
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098982A1)

Countries: Argentina Date: 2016
CILFA opposition, MELOXICAM, (AR100293A2)

Countries: Argentina Date: 2016
CILFA opposition, Aclidinium, (AR095705A1)

Countries: Argentina Date: 2016
CILFA opposition, GLICOPYRRONIUM-FORMOTEROL, (AR098983A1)

Countries: Argentina Date: 2016

Cilfa Opposition, ácido Hialurónico, (Ar098201 A1)